 ELMWOOD PARK, N.J., March 26, 2021 PRNewswire -- BioReference Laboratories, Inc., an OPKO Health company NASDAQ: OPK, today announced the expansion of its COVID-19 school testing program to support the return to in-person classroom instruction across the country. 